Latest News about Epidiolex
Recent news which mentions Epidiolex
PreMarket Prep Stock Of The Day: GW Pharmaceuticals
December 03, 2020
From Benzinga
From Benzinga
BofA Sees Blockbuster Sales Potential For GW Pharma's CBD Drug Epidiolex
February 04, 2020
From Benzinga
From Benzinga
'Exceeded Our Expectations': First Latin American Study On CBD, Epilepsy Completed
December 07, 2019
From Benzinga
Brace For Stricter FDA Regulation Of CBD Consumer Products, Analysts Say
November 26, 2019
From Benzinga
From Benzinga
UK Recommends NHS Reimburse GW Pharma's CBD-Based Epilepsy Drug
November 12, 2019
From Benzinga
Analysts Remain Upbeat On GW Pharma's Optionality With Epidiolex
November 06, 2019
Tickers
GWPH
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
GW Pharma Posts Second-Quarter Epidiolex Sales Of $68.4M
August 06, 2019
From Benzinga
From Benzinga
GW Pharma's CBD Drug Epidiolex Could Secure Label Expansion Following Positive Trial Results
May 07, 2019
From Benzinga
From Benzinga
From Benzinga
Cantor Reiterates Bullish View On GW Pharmaceuticals Following Earnings
February 27, 2019
Tickers
GWPH
From Benzinga
GW Pharmaceuticals Sees 68% Q1 Revenue Growth Following Epidiolex Launch
February 26, 2019
From Benzinga
From Benzinga
Bank Of America Bullish On GW Pharma, Expects Growth In Epidiolex Sales
December 04, 2018
Tickers
GWPH
From Benzinga
Leerink Out Bullish On GW Pharma: 4 Reasons Why
November 14, 2018
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.